Article Versions Notes

de Souza ZS, Xavier CB, Gomes LBM, de Medeiros MFB, de Sousa MC, Pereira AAL, Marin JFG, Buchpiguel CA, Costa FP. Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience. Cancers. 2023; 15(18):4506. https://doi.org/10.3390/cancers15184506

de Souza, Zenaide Silva, Camila Bragança Xavier, Luciana Beatriz Mendes Gomes, Maria Fernanda Barbosa de Medeiros, Micelange Carvalho de Sousa, Allan Andresson Lima Pereira, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, and Frederico Perego Costa. 2023. "Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience" Cancers 15, no. 18: 4506. https://doi.org/10.3390/cancers15184506

de Souza, Z. S., Xavier, C. B., Gomes, L. B. M., de Medeiros, M. F. B., de Sousa, M. C., Pereira, A. A. L., Marin, J. F. G., Buchpiguel, C. A., & Costa, F. P. (2023). Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience. Cancers, 15(18), 4506. https://doi.org/10.3390/cancers15184506